A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder

Clinical trial NCT01143090 · COMPLETED

Trial details

NCT number: NCT01143090
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2010-08-01
Primary completion: 2011-11-01
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.